ID: ALA373998

Max Phase: Preclinical

Molecular Formula: C27H25N3O3

Molecular Weight: 439.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cn(C/C=C\COC(c2ccccc2)(c2ccccc2)c2ccncc2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C27H25N3O3/c1-21-20-30(26(32)29-25(21)31)18-8-9-19-33-27(22-10-4-2-5-11-22,23-12-6-3-7-13-23)24-14-16-28-17-15-24/h2-17,20H,18-19H2,1H3,(H,29,31,32)/b9-8-

Standard InChI Key:  FVXBVGUSRQAIDN-HJWRWDBZSA-N

Associated Targets(Human)

Thymidine kinase, mitochondrial 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Thymidine kinase 140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Deoxynucleoside kinase 95 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 439.52Molecular Weight (Monoisotopic): 439.1896AlogP: 3.80#Rotatable Bonds: 8
Polar Surface Area: 76.98Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.31CX Basic pKa: 4.96CX LogP: 4.18CX LogD: 4.18
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.42Np Likeness Score: -0.40

References

1. Hernandez AI, Familiar O, Negri A, Rodríguez-Barrios F, Gago F, Karlsson A, Camarasa MJ, Balzarini J, Pérez-Pérez MJ..  (2006)  N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.,  49  (26): [PMID:17181158] [10.1021/jm0610550]

Source